Prenatal diagnosis of Desbuquois dysplasia Type 1: Utilization of high-density SNP array to map homozygosity and identify the gene.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
12 2019
Historique:
received: 30 06 2019
revised: 30 08 2019
accepted: 11 09 2019
pubmed: 7 10 2019
medline: 18 8 2020
entrez: 7 10 2019
Statut: ppublish

Résumé

Desbuquois dysplasia (DBQD1 [MIM 251450]) is an autosomal recessive chondrodysplasia with micromelia, severe joint laxity and dislocations, and a characteristic radiographic "monkey wrench" appearance at the proximal femur. Type 1 Desbuquois dysplasia is caused by mutations in CANT1 and is distinct from Type 2, caused by mutations in XYLT1, in that the former has unique hand anomalies including accessory phalangeal ossification centers, advanced carpal bone maturation, and/or axial phalangeal deviation. Severe prenatal presentations have been rarely reported. We report a Pakistani female in a consanguineous relationship with a diagnosis of Type 1 Desbuquois dysplasia in three consecutive pregnancies. Multiple similar severe fetal limb anomalies were detected by ultrasound in Pregnancy 1 and 2. Regions of homozygosity within the single nucleotide polymorphism (SNP)-microarray from both terminated fetuses were compared, revealing CANT1 as a likely disease-causing candidate gene. Insufficient fetal DNA precluded confirmatory testing, therefore parents were tested; both had a previously reported heterozygous CANT1 mutation (c.643G>T; Glu215Term). The patient presented with a third pregnancy revealing similarly abnormal limb position and probable polysyndactyly by ultrasound. Targeted testing of CANT1 revealed homozygous c.643G>T CANT1 mutations and this pregnancy was terminated. In clinical situations in which ample DNA is not available or more expensive testing (e.g., whole exome sequencing) with a longer turnaround time is not feasible, utilization of SNP-microarray in consanguineous families at risk for rare autosomal recessive disorders may dramatically narrow the list of candidate genes.

Identifiants

pubmed: 31587486
doi: 10.1002/ajmg.a.61372
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2490-2493

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Alkuraya, F. S. (2010). Homozygosity mapping: One more tool in the clinical geneticist's toolbox. Genetics in Medicine, 12(4), 236-239.
American College of Obstetricians and Gynecologists. (2013). Committee opinion no 581: The use of microarray analysis in prenatal diagnosis. Obstetrics and Gynecology, 122(6), 1374-1377.
Baynam, G., Kiraly-Borri, C., Goldblatt, J., Dickinson, J. E., Jevon, G. P., & Overkov, A. (2010). A recurrence of a hydrops lethal skeletal dysplasia showing similarity to Desbuquois dysplasia and a proposed new sign: The upsilon sign. American Journal of Medical Genetics. Part A, 152A(4), 966-969.
Bui, C., Huber, C., Tuysuz, B., Alanay, Y., Bole-Feysot, C., Leroy, J. G., … Cormier-Daire, V. (2014). XYLT1 mutations in Desbuquois dysplasia type 2. American Journal of Human Genetics, 94(3), 405-414.
Desbuquois, G., Grenier, B., Michel, J., & Rossignol, C. (1966). Nanisme chondrodystrophique avec ossification anarchique et polymalformations chez deux soeurs. Archives Franc Pédiatrie, 23, 573-587.
Gillessen-Kaesbach, G., Meinecke, P., Ausems, M. G., Nöthen, M., Albrecht, B., Beemer, F. A., & Zerres, K. (1995). Desbuquois syndrome: Three further cases and review of the literature. Clinical Dysmorphology, 4(2), 136-144.
Faivre, L., Cormier-Daire, V., Eliott, A. M., Field, F., Munnich, A., Maroteaux, P., … Lachman, R. (2004). Desbuquois dysplasia, a reevaluation with abnormal and “normal” hands: Radiographic manifestations. American Journal of Medical Genetics. Part A, 124A(1), 48-53.
Hall, B. D. (2001). Lethality in Desbuquois dysplasia: Three new cases. Pediatric Radiology, 31(1), 43-47.
Huber, C., Oulès, B., Bertoli, M., Chami, M., Fradin, M., Alanay, Y., … Cormier-Daire, V. (2009). Identification of CANT1 mutation in Desbuquois dysplasia. American Journal of Human Genetics, 85(5), 706-710.
Inoue, S., Ishii, A., Shirotani, G., Tsutsumi, M., Ohta, E., Nakamura, M., … Hirose, S. (2014). Case of Desbuquois dysplasia type 1: Potentially lethal skeletal dysplasia. Pediatrics International, 56(4), e26-e29.
Laccone, F., Schroner, K., Krabichler, B., Kluge, B., Schwerdtfeger, R., Schulze, B., … Rehder, H. (2011). Desbuquois dysplasia type 1 and fetal hydrops due to novel mutations in the CANT1 gene. European Journal of Human Genetics, 19(11), 1133-1137.
Manning, M., & Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine, 12(11), 742-745.
Nishimura, G., Hong, H. S., Kawame, H., Sato, S., Cai, G., & Ozono, K. (1999). A mild variant of Desbuquois dysplasia. European Journal of Pediatrics, 158(6), 479-483.
Sheridan, M., Wohler, E., Batista, D. A. S., Applegate, C., & Hoover-Fong, J. (2015). The use of high-density SNP array to map homozygosity in consanguineous families to efficiently identify candidate genes: Application to woodhouse-Sakati syndrome. Case Reports in Genetics, 2015, 6.
Srivastava, P., Saxena, D., Joshi, S., & Phadke, S. R. (2016). Consanguinity as an adjunct diagnostic tool. Indian Journal of Pediatrics, 83(3), 258-260.
Sund, K. L., Zimmerman, S. L., Thomas, C., Mitchell, A. L., Prada, C. E., Grote, L., … Smolarek, T. A. (2013). Regions of homozygosity identified by SNP microarray analysis aid in the diagnosis of autosomal recessive disease and incidentally detect parental blood relationships. Genetics in Medicine, 15(1), 70-78.

Auteurs

Katherine R Forster (KR)

Johns Hopkins Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland.

Jody E Hooper (JE)

Department of Pathology, Johns Hopkins University, Baltimore, Maryland.

Karin J Blakemore (KJ)

Maternal Fetal Medicine, Department of Gynecology and Obstetrics, McKusick-Nathans Institute of the Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland.

Ahmet A Baschat (AA)

Johns Hopkins Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland.

Julie Hoover-Fong (J)

Greenberg Center for Skeletal Dysplasias, McKusick-Nathans Institute of the Department of Genetic Medicine, Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH